Stroke-Vascular and Interventional Neurology, published by WILEY, is a leading open-access journal dedicated to advancing the field of neurology with a particular focus on stroke and vascular interventions. Since its inception in 2021 as an open-access journal, it has fostered a collaborative environment for researchers, clinicians, and educators to share innovative findings and clinical practices that address the complexities of cerebrovascular diseases. The journal emphasizes high-quality, peer-reviewed research articles, reviews, and case studies, providing critical insights into cutting-edge therapies and surgical techniques. With an ISSN of 2694-5746, it aims to support the global medical community in improving the diagnosis, treatment, and overall management of stroke patients. Researchers and healthcare professionals benefit from its accessible content, which is vital for fostering comprehensive understanding and evidence-based practices within the realm of interventional neurology.

Archives of Neuroscience is a multidisciplinary journal dedicated to advancing the field of neuroscience through the publication of original research articles, review papers, and case studies. Published by BRIEFLAND, this journal aims to bridge the gap between neuroscience research and clinical applications, fostering a deeper understanding of brain function, neurological disorders, and potential therapeutic approaches. With an ISSN of 2322-3944 and an E-ISSN of 2322-5769, Archives of Neuroscience serves as an essential platform for researchers, professionals, and students alike, encouraging open access to knowledge and insights that drive innovation in the field. Although coverage was discontinued in Scopus from 2016 to 2017, the journal continues to uphold rigorous standards of academic excellence, making it a valuable resource for the neuroscience community seeking to explore and disseminate new findings. The journal is committed to providing timely access to research tools and findings that are crucial for informed decision-making in both academic and clinical settings.

The European Stroke Journal, published by SAGE Publications Ltd, is a pivotal resource in the domains of Cardiology and Neurology, reflecting its commitment to advancing knowledge and research in these critical areas of medicine. Since its inception in 2016, this journal has rapidly gained recognition, achieving a prestigious Q1 ranking in both Cardiology and Neurology (clinical) as of 2023, placing it among the top quartile publications in these fields. With a prominent position, ranked 65th and 72nd respectively in Scopus for Cardiology and Neurology, the journal caters to a diverse audience of researchers, clinicians, and students dedicated to improving stroke treatment and prevention strategies. Although it operates under a traditional access model, its impactful publications are essential for anyone involved in stroke research, ensuring they remain at the forefront of scientific developments and clinical practices.

Annals of Indian Academy of Neurology is a premier open access journal dedicated to advancing the field of Neurology, serving as a vital resource for researchers, healthcare professionals, and students since its inception in 2006. Published by the esteemed Wolters Kluwer Medknow Publications, this journal has established itself within the academic community, boasting a Q3 quartile ranking in clinical neurology according to the 2023 category quartiles and a Scopus rank placing it in the 35th percentile among 400 comparable journals. With a focus on clinical advancements and research innovations in neurology, the journal aims to disseminate high-quality and impactful studies that address the complex challenges faced in the neurological landscape, particularly within the Indian context. The open access model ensures that the latest research is readily accessible to a global audience, thereby promoting collaboration and knowledge sharing within the neurosciences.

Cerebrovascular Diseases Extra is a distinguished open-access journal published by KARGER, operating out of Switzerland since 2011. With ISSN 1664-5456, this journal aims to bridge the gap in knowledge surrounding cerebrovascular diseases, an essential segment of both Cardiology and Cardiovascular Medicine as well as Neurology. Ranked in the third quartile by Scopus for various categories, including Cardiology, Neurology, and Clinical Neurology, it is specially designed for academics, clinicians, and researchers who seek to disseminate and gain insights into the latest advancements and research findings in these critical areas. By embracing open access, it amplifies the reach and impact of its published research, ensuring that vital information is readily accessible to a global audience. As the journal converges towards its targeted years from 2015 to 2024, it remains a pivotal platform for fostering innovative ideas and collaborative research in cerebrovascular health.

Journal of Stroke & Cerebrovascular Diseases, published by ELSEVIER, is a leading international peer-reviewed journal dedicated to advancing the research and understanding of stroke and cerebrovascular disorders. With an impressive impact factor reflective of its rigorous academic standards, this journal is indexed in the highest echelons of medical disciplines, boasting a Q1 classification in Rehabilitation and prominent rankings in related fields. Established in 1991 and converging its focus toward 2024, it serves as a vital resource for researchers and clinicians interested in the complexities and treatment of cerebrovascular conditions. The journal's broad scope spans essential categories such as cardiology, neurology, and surgery, making significant contributions that enhance clinical practices and patient outcomes. For researchers, professionals, and students alike, the Journal of Stroke & Cerebrovascular Diseases is not just a publication but a critical platform for sharing innovative findings and fostering impactful discussions within the medical community.

Stroke Research and Treatment is a premier Open Access journal published by HINDAWI LTD, dedicated to advancing the understanding and management of stroke and related neurological disorders. Since its inception in 2010, this journal has established itself as a valuable resource for researchers and clinicians in the field of neurology, providing a platform for high-quality, peer-reviewed articles that aim to improve patient outcomes and stimulate clinical practice innovations. With a 2023 Scopus ranking placing it in the Q3 category and a percentile ranking of 44th in clinical neurology, the journal is positioned to influence the ongoing discourse in stroke research. Stroke Research and Treatment embraces a global audience, with its editorial operations based in London, England. The journal's commitment to open access ensures that its content is freely available to all, promoting extensive dissemination and engagement in this critical field of study. Researchers, professionals, and students are encouraged to contribute their findings to this dynamic journal, fostering collaboration and knowledge sharing in the ongoing fight against stroke.

CEREBROVASCULAR DISEASES is a prestigious journal published by KARGER that focuses on the critical field of cerebrovascular health, encompassing research and advancements in cardiology and neurology. With a strong emphasis on high-quality, peer-reviewed publications, the journal has established itself as an essential resource since its inception in 1987, contributing to the understanding and management of cerebrovascular disorders. It holds a commendable Q2 ranking across various categories, including Cardiology and Cardiovascular Medicine, which underscores its influence within the research community. The journal is especially significant for professionals and researchers interested in the intersection of neurological and cardiovascular health, facilitating knowledge sharing and innovative research. Although it does not operate under an Open Access model, the journal is well-regarded for its rigorous selection criteria and impactful findings. By continuing to publish cutting-edge research, CEREBROVASCULAR DISEASES aims to foster advancements in treatment and prevention strategies for cerebrovascular diseases, thereby contributing to improved patient outcomes worldwide.

NEUROLOGY, published by Lippincott Williams & Wilkins, stands as a premier journal in the field of neurology, holding an esteemed Q1 category ranking in clinical neurology as of 2023. Established in 1951, this journal has been a critical resource for the dissemination of cutting-edge research and clinical advancements, with an impressive Scopus rank of 24 out of 400, placing it in the 94th percentile among its peers. NEUROLOGY serves as a vital platform for neurologists, researchers, and medical professionals seeking to stay abreast of the latest findings and innovations in the treatment and understanding of neurological disorders. With its rigorous peer-review process and commitment to excellence, NEUROLOGY remains essential reading for all individuals dedicated to advancing the science and practice of neurology, contributing significantly to the ongoing dialogue in this vital area of medicine.

European Neurology, published by KARGER, is a distinguished journal in the field of neurology, catering to both clinical and neuroscience specialties. Since its inception in 1897 and continuing through 2024, the journal has been a vital platform for disseminating significant research findings and insights in neurology. With an ISSN of 0014-3022 and E-ISSN of 1421-9913, it ranks in the Q3 quartile in both clinical neurology and general neurology categories, reflecting its commitment to scholarly excellence while holding the 175th rank in clinical medicine and the 93rd in neuroscience, according to Scopus metrics. European Neurology facilitates a deeper understanding of neurological disorders and treatments, appealing to a diverse readership that includes researchers, clinicians, and students alike. Despite not currently offering open access, the journal’s rigorous peer-review process ensures that only high-quality research reaches its audience, making it an essential resource for those looking to stay informed in the rapidly evolving field of neurology.